Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -COVID-19 positive as determined by RT-PCR or other approved commercial or public health assay -Informed consent for the study -Asymptomatic stage -mild stage (cough, fever) -Respiratory rate saturation > 94%
Exclusion criteria
Exclusion criteria: -Participation in any other clinical trial of an experimental treatment for COVID-19 -Patients with severe COVID-19 disease defined as follows respiratory distress,oxygen saturation at rest complications. Pregnant women or women who are breastfeeding -Immunocompromised patients taking (presently on immunosuppressant medication any time during last 90 days) -Diabetics with >9% HbA1c -Patients on antimicrobials, antibiotics, antifungals during last 30 days -Patients with active malignancy -patients with bleeding disorders -Pandu (Hb
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To prevent covid19 postive cases in asymptomatic and mild stages progressing into moderate and severe stages assessed by clinical and laboratory parameters and to find the time taken to convert SARSâ??CoVâ??2 negative determined by RT-PCR.Timepoint: Participants will be provided with study medication orally for 21 days, with close follow-up on weekly basis. -Baseline -7th day -14th day -21st day | — |
Secondary
| Measure | Time frame |
|---|---|
| No of cases Reporting any ADR/AE assessed clinically and by laboratory parameters(CBC,CRP,LFT,urea,creatinine)Timepoint: -Baseline -7th day -14th day -21st day | — |
Countries
India
Contacts
Government Ayurveda Medical College and Hospital,Kottar